These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6136141)

  • 21. Pharmacological evidence for opioid and adrenergic mechanisms controlling growth hormone, prolactin, pancreatic polypeptide, and catecholamine levels in humans.
    Thompson DA; Pénicaud L; Welle SL; Jacobs LS
    Metabolism; 1985 Apr; 34(4):383-90. PubMed ID: 3982277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the metabolic responses to alpha-adrenergic stimulation in asthmatics and non-asthmatics after clonidine.
    Kallenbach JM; Joffe BI; Seftel HC; Zwi S
    S Afr Med J; 1984 Jan; 65(4):131-4. PubMed ID: 6320477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Presynaptic alpha 2 -adrenergic stimulation leads to growth hormone release in the dog.
    Cella SG; Picotti GB; Morgese M; Mantegazza P; Müller EE
    Life Sci; 1984 Jan; 34(5):447-54. PubMed ID: 6141513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New evidence for growth hormone modulation by the alpha-adrenergic system in man.
    Lancranjan I; Marbach P
    Metabolism; 1977 Nov; 26(11):1225-30. PubMed ID: 20551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deranged alpha-adrenergic regulation of growth hormone secretion in poorly controlled diabetes: reversal of the exaggerated response to clonidine after continuous subcutaneous insulin infusion.
    Topper E; Gertner J; Amiel S; Press M; Genel M; Tamborlane WV
    Pediatr Res; 1985 Jun; 19(6):534-6. PubMed ID: 2989759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of fetal ethanol exposure on the in vitro release of growth hormone, somatostatin and growth hormone-releasing factor induced by clonidine and growth hormone feedback in male and female rats.
    Conway S; Ling SY; Leidy JW; Blaine K; Holtzman T
    Alcohol Clin Exp Res; 1997 Aug; 21(5):826-39. PubMed ID: 9267532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction between opiate subtype and alpha-2 adrenergic agonists in suppression of noxiously evoked activity of WDR neurons in the spinal dorsal horn.
    Omote K; Kitahata LM; Collins JG; Nakatani K; Nakagawa I
    Anesthesiology; 1991 Apr; 74(4):737-43. PubMed ID: 1672579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sympathetic neural activation evoked by mu-receptor blockade in patients addicted to opioids is abolished by intravenous clonidine.
    Kienbaum P; Heuter T; Michel MC; Scherbaum N; Gastpar M; Peters J
    Anesthesiology; 2002 Feb; 96(2):346-51. PubMed ID: 11818767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. II. GH and PRL release-inhibiting effects of the opioid kappa receptor agonists bremazocine and U-50,488.
    Krulich L; Koenig JI; Conway S; McCann SM; Mayfield MA
    Neuroendocrinology; 1986; 42(1):82-7. PubMed ID: 3001566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative effects of central administration of naloxone and clonidine on the blood pressure and heart rate response to anterior and posterior hypothalamic stimulation.
    Rabkin SW
    Life Sci; 1994; 54(22):1649-57. PubMed ID: 8177007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of adrenergic and cholinergic stimulation on islet monoamine oxidase activity and insulin secretion in the mouse.
    Panagiotidis G; Stenström A; Lundquist I
    Eur J Pharmacol; 1993 Mar; 233(2-3):285-90. PubMed ID: 8096820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The paradox of alpha 2 adrenergic regulation of prolactin (PRL) secretion. I. The PRL-releasing action of the alpha 2 receptor agonists.
    Jurcovicová J; Le T; Krulich L
    Brain Res Bull; 1989 Dec; 23(6):417-24. PubMed ID: 2575439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence that alpha 2-adrenergic pathways play a major role in growth hormone (GH) neuroregulation: alpha 2-adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone, while alpha 2-adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men.
    Devesa J; Diaz MJ; Tresguerres JA; Arce V; Lima L
    J Clin Endocrinol Metab; 1991 Aug; 73(2):251-6. PubMed ID: 1677361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of intracerebroventricular clonidine on the hypothalamic noradrenaline and plasma corticosterone levels of opiate naive rats and after naloxone-induced withdrawal.
    Gonzalvez ML; Milanés MV; Martinez-Piñero MG; Marín MT; Vargas ML
    Brain Res; 1994 Jun; 647(2):199-203. PubMed ID: 7922496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absence of opiate and histamine H2 receptor-mediated effects of clonidine.
    Watkins J; FitzGerald G; Zamboulis C; Brown MJ; Dollery CT
    Clin Pharmacol Ther; 1980 Nov; 28(5):605-10. PubMed ID: 6254720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variable plasma growth hormone (GH)-releasing hormone and GH responses to clonidine, L-dopa, and insulin in normal men.
    Tapanainen P; Knip M; Lautala P; Leppäluoto J
    J Clin Endocrinol Metab; 1988 Oct; 67(4):845-9. PubMed ID: 3138280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postoperative alpha 2-adrenergic stimulation attenuates protein catabolism: effects of clonidine on growth hormone secretion.
    Klis R; Girbes AR; Zwaveling JH
    Anesth Analg; 1996 Nov; 83(5):1135. PubMed ID: 8895312
    [No Abstract]   [Full Text] [Related]  

  • 38. The pattern of testosterone replacement influences the recovery of the stimulatory effect of clonidine on growth hormone (GH) secretion in orchidectomized rats.
    Tena-Sempere M; Pinilla L; Aguilar E
    J Steroid Biochem Mol Biol; 1996 Aug; 58(5-6):533-8. PubMed ID: 8918979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alpha 2-adrenergic agonism enhances the growth hormone (GH) response to GH-releasing hormone through an inhibition of hypothalamic somatostatin release in normal men.
    Devesa J; Arce V; Lois N; Tresguerres JA; Lima L
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1581-8. PubMed ID: 1977761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth hormone, prolactin and cortisol nyctohemeral variations during naloxone-induced opiate receptor blockade in man.
    Delitala G; Giusti M; Rodriguez G; Mazzocchi G; Ferrini S; Baccelliere L; Montano V; Rosadini G; Giordano G
    Acta Endocrinol (Copenh); 1982 Jul; 100(3):321-6. PubMed ID: 6287782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.